CAS: 1259519-18-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Neratinib-d6 REF: 4Z-N-088015CAS: | - - - | To inquire | Tue 14 Jan 25 |
 | Neratinib-d6 REF: TR-N390092CAS: 1259519-18-0 | - - - | 303.00 €~3,900.00 € | Wed 15 Jan 25 |
 | Neratinib-d6 REF: 3D-JAC51918CAS: 1259519-18-0 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: 4Z-N-088015
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Neratinib-d6
Controlled ProductCAS:1259519-18-0
Applications Labelled Neratinib (N390090). An oral, irreversible dual EGFR/HER2 inhibitor for breast and non-small cell …
Formula:
C30H23D6ClN6O3
Color and Shape:
Neat
Molecular weight:
563.08
Ref: TR-N390092
| 1mg | 512.00 € | ||
| 5mg | 303.00 € | ||
| 10mg | 3,900.00 € | ||
| 25mg | 1,263.00 € | ||
| 50mg | 2,077.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Neratinib-d6
CAS:1259519-18-0
Neratinib-d6 is a potent inhibitor of cancer cell growth and is used in the treatment …
Formula:
C30H29ClN6O3
Purity:
Min. 95%
Molecular weight:
563.1 g/mol
Ref: 3D-JAC51918
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
